Home › Colon Cancer › Illinois › Chicago
Pag-aaral pangklinika para sa Colon Cancer sa Chicago, IL
14 pag-aaral para sa Colon Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Chicago (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Family Communications After Genetic Testing
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Advocate Illinois Masonic Medical Center, Chicago
PRE-ISPY Phase I/II Oncology Platform Program
Nagre-recruitPhase 1/2
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Nagre-recruitPhase 3
- Illinois Cancer Specialists, Chicago
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Nagre-recruitPhase 3
- University of Illinois Cancer Center, Chicago
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Nagre-recruit
- John H Stroger Jr Hospital of Cook County, Chicago
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Nagre-recruitPhase 2/3
- Mount Sinai Hospital Medical Center, Chicago
- Northwestern University, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- at 5 pa
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
Nagre-recruitPhase 1/2
- Northwestern University, Chicago
Shield Post-Approval Study Protocol
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- GI Solutions of Illinois, Chicago
- GI Solutions of Illinois, Chicago
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Nagre-recruitPhase 1
- Xencor Investigative Site, Chicago
- Xencor Investigative Site, Chicago
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
Nagre-recruitPhase 2
- City of Hope at Illinois Chicago Downtown, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Nagre-recruitPhase 1/2
- University of Chicago, Chicago
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine, Chicago
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Nagre-recruitPhase 3
- GSK Investigational Site, Chicago
- GSK Investigational Site, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Chicago
Pag-aaral para sa Colon Cancer sa ibang lungsod
- Boston, MA22 pag-aaral
- New York City, NY22 pag-aaral
- Houston, TX20 pag-aaral
- Los Angeles, CA16 pag-aaral
- Nashville, TN16 pag-aaral
- St. Louis, MO15 pag-aaral
- Arlington, VA15 pag-aaral
- San Antonio, TX14 pag-aaral
- Baldwin Park, CA14 pag-aaral
- Baltimore, MD13 pag-aaral
- Tampa, FL13 pag-aaral
- Washington, DC12 pag-aaral
Iba pang pag-aaral sa Chicago
- Non-Small Cell Lung Cancer61 pag-aaral
- Kanser sa Suso59 pag-aaral
- Kanser (lahat ng uri)51 pag-aaral
- Metastatic Cancer45 pag-aaral
- Kanser sa Prostate45 pag-aaral
- Kanser sa Baga41 pag-aaral
- Obesity41 pag-aaral
- Kanser sa Ovary36 pag-aaral
- Colorectal Cancer34 pag-aaral
- Stroke34 pag-aaral
- Pagkabigo ng Puso31 pag-aaral
- Overweight29 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.